Identification of a novel structure in heparin generated by potassium permanganate oxidation

Carbohydrate Polymers

Volumn 82, Issue 3, 2010, Pages 699-705

  Beccati, Daniela ^a   Roy, Sucharita ^a   Yu, Fei ^a   Gunay, Nur Sibel ^a   Capila, Ishan ^a   Lech, Miroslaw ^a   Linhardt, Robert J ^b   Venkataraman, Ganesh ^a  

^a Momenta Pharmaceuticals Inc   (United States)

^b RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

1H NMR; Heparin; HSQC; N Acetylglucosamine; Oxidation; Permanganate; Reducing end

Indexed keywords

1H NMR; HEPARIN; HSQC; N-ACETYLGLUCOSAMINE; PERMANGANATE; REDUCING ENDS;

MANUFACTURE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION; POTASSIUM; SODIUM;

POLYSACCHARIDES;

EID: 77955655323     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2010.05.038     Document Type: Article

References (14)

1. B. Casu, and G. Torri Structural Characterization of Low Molecular Weight Heparins Seminars in Thrombosis and Hemostasis 25 Suppl. 3 1999 17 25
2. H.E. Conrad Heparin-binding proteins 1998 Academic Press
3. M. Guerrini, D. Beccati, Z. Shriver, A. Naggi, K. Viswanathan, and A. Bisio Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events Nature Biotechnology 26 2008 669 675
4. M. Guerrini, S. Guglieri, A. Naggi, R. Sasisekharan, and G. Torri Low molecular weight heparins: Structural differentiation by bidimensional nuclear magnetic resonance spectroscopy Seminars in Thrombosis and Hemostasis 33 2007 478 487
5. N.S. Gunay, and R.J. Linhardt Heparinoids: Structure biological activities and therapeutic applications Planta Medica 65 1999 301 306
6. M. Jaseja, R.N. Rej, F. Sauriol, and A.S. Perlin Novel regio-and stereoselective modifications of heparin in alkaline solution nuclear magnetic resonance spectroscopic evidence Canadian Journal of Chemistry 67 1989 1449 1456
7. T.K. Kishimoto, K. Viswanathan, T. Ganguly, S. Elankumaran, S. Smith, and K. Pelzer Contaminated heparin associated with adverse clinical events and activation of the contact system New England Journal of Medicine 358 2008 2457 2467
8. A.L. Lewis, V. Nizet, and A. Varki Discovery and characterization of sialic acid O-acetylation in group B Streptococcus Proceedings of the National Academy of Sciences of United States of America 101 2004 11123 11128
9. U. Lindahl Heparin-from anticoagulant drug into the new biology Glycoconjugate Journal 17 2000 597 605
10. R.J. Linhardt 2003 Claude S.Hudson Award Address in Carbohydrate Chemistry. Heparin: structure and activity Journal of Medicinal Chemistry 46 2003 2551 2564
11. M. Petitou, B. Casu, and U. Lindahl 1976-1983, a critical period in the history of heparin: The discovery of antithrombin binding site Biochimie 85 2003 83 89
12. K. Sugahara, and H. Kitagawa Heparin and heparan sulfate biosynthesis IUBMB Life 54 2002 163 175
13. T. Toida, I.R. Vlahov, A.E. Smith, R.E. Hileman, and R.J. Linhardt C-2 epimerization of N-acetylglucosamine in an oligosaccharide derived from heparan sulfate Journal of Carbohydrate Chemistry 15 1996 351 360
14. H. Uchiyama, Y. Dobashi, K. Ohkouchi, and K. Nagasawa Chemical change involved in the oxidative reductive depolymerization of hyaluronic acid Journal of Biological Chemistry 265 1990 7753 7759